The extended-wear hearing aid (EWHA) is a hearing assistive device that combines a low-power analog amplification circuit with a soft biocompatible foam plug that allows it to remain in the ear canal for several months at a time without replacement. EWHAs fit snugly in the ear canal and are not vented and so produce insertion losses comparable to a passive earplug when inserted into the ear canal with the active circuitry turned off. However, EWHAs are not marketed as hearing protection devices, and other than a general warning to users that the device will have impaired auditory awareness when the device is inserted in the "off" mode, relatively little has been reported about the attenuation characteristics of EWHAs. In this study, commercially-available EWHAs were evaluated using the ANSI standard procedures for measuring hearing protector attenuation in impulse noise [ANSI (2010). S1242-2010, Methods for the Measurement of Insertion Loss of Hearing Protective Devices in Continuous or Impulsive Noise Using Microphone-In-Real-Ear or Acoustic Text Fixture Procedures (American National Standards Institute, New York)] and in continuous noise [ANSI (2006). S12.6, Methods for Measuring the Real-Ear Attenuation of Hearing Protectors (American National Standards Institute, New York)]. Attenuation values were also measured in double and triple protection conditions that combined EWHAs with traditional earplugs and earmuffs. The results show that properly-fit EWHAs can provide passive attenuation comparable to conventional passive earplugs, which may make it possible to use them to provide persistent protection from intermittent noise sources.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1121/10.0001899 | DOI Listing |
J Clin Med
December 2024
Department of Radiology, Cerrahpaşa Medical Faculty, İstanbul University-Cerrahpaşa, 34147 Istanbul, Türkiye.
Congenital hearing loss is a significant health concern, with diverse etiologies encompassing cochlear and cochleovestibular pathologies. Preoperative radiological evaluation in cochlear implant candidates is pivotal for treatment planning. We aim to elucidate the spectrum of radiological findings in patients with congenital hearing loss undergoing cochlear implant assessment.
View Article and Find Full Text PDFChildren (Basel)
November 2024
Department of Health Promotion Sciences, Maternal and Child Care, Internal Medicine and Medical Specialties 'Giuseppe D'Alessandro', University of Palermo, Via del Vespro 133, 90127 Palermo, Italy.
Background/objectives: The respiratory system is prone to infectious diseases, especially in children below five years of age. Upper respiratory tract infections in children are often associated with Eustachian tube dysfunction and complicated by otitis media with effusion (OME), an inflammatory process within the middle ear, which can lead to hearing loss. Treatment for these infections involves a combination of medication and symptom relief, depending on the severity and cause of the infection.
View Article and Find Full Text PDFBiomolecules
December 2024
Department of Otolaryngology, UCSD School of Medicine, La Jolla, San Diego, CA 92093-0666, USA.
The tympanic membrane forms an impenetrable barrier between the ear canal and the air-filled middle ear, protecting it from fluid, pathogens, and foreign material entry. We previously screened a phage display library and discovered peptides that mediate transport across the intact membrane. The route by which transport occurs is not certain, but possibilities include paracellular transport through loosened intercellular junctions and transcellular transport through the cells that comprise the various tympanic membrane layers.
View Article and Find Full Text PDFBraz J Otorhinolaryngol
January 2025
Ankara Yıldırım Beyazıt University Faculty of Medicine, Department of Otorhinolaryngology, Ankara, Turkey.
Objectives: The aim of this study was to investigate the risk factors that may cause postoperative otomycosis in patients undergoing Chronic Nonsuppurative Otitis Media (CNSOM) surgery.
Methods: In this retrospective study, 409 out of 523 patients met the inclusion criteria. 44 patients diagnosed with otomycosis CNSOM were analyzed.
Ann Otol Rhinol Laryngol
January 2025
Department of Otolaryngology-Head and Neck Surgery, University Hospitals Cleveland Medical Center, Cleveland, OH, USA.
Objectives: The primary objective of this case series is to assess the effectiveness of the off-label use of the PROPEL drug-eluting stent, traditionally FDA-approved for sinus surgery, in preventing restenosis following canalplasty in patients with chronic otologic conditions or congenital anomalies. The stent provides both mechanical support to maintain canal patency and localized steroid delivery to reduce inflammation and scarring.
Methods: Four patients with various otologic conditions underwent canalplasty, followed by the placement of drug-eluting stents into the external auditory canal.
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!